These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33660801)

  • 1. Curcumin-Celecoxib: a synergistic and rationale combination chemotherapy for breast cancer.
    Alqahtani AM; Chidambaram K; Pino-Figueroa A; Chandrasekaran B; Dhanaraj P; Venkatesan K
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1916-1927. PubMed ID: 33660801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib induced apoptosis against different breast cancer cell lines by down-regulated NF-κB pathway.
    Wang G; Li J; Zhang L; Huang S; Zhao X; Zhao X
    Biochem Biophys Res Commun; 2017 Aug; 490(3):969-976. PubMed ID: 28666869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitivity enhancement by combined treatment of nimotuzumab and celecoxib on nasopharyngeal carcinoma cells.
    Huang J; Yuan X; Pang Q; Zhang H; Yu J; Yang B; Zhou L; Zhang F; Liu F
    Drug Des Devel Ther; 2018; 12():2223-2231. PubMed ID: 30038488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Combined Treatment with Vitamin D and COX2 Inhibitors on Breast Cancer Cell Lines.
    Friedrich M; Reichert K; Woeste A; Polack S; Fischer D; Hoellen F; Rody A; Köster F; Thill M
    Anticancer Res; 2018 Feb; 38(2):1201-1207. PubMed ID: 29374758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells.
    Lev-Ari S; Zinger H; Kazanov D; Yona D; Ben-Yosef R; Starr A; Figer A; Arber N
    Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S276-80. PubMed ID: 16507392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells.
    Sugimoto T; Bartholomeusz C; Tari AM; Ueno NT
    Breast Cancer Res; 2007; 9(4):R41. PubMed ID: 17612393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
    Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
    Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and Metabolomic Investigation of Celecoxib Antiproliferative Activity in Mono-and Combination Therapy against Breast Cancer Cell Models.
    Bardaweel SK; Dahabiyeh LA; Akileh BM; Shalabi DD; AlHiary AK; Pawling J; Dennis JW; Rahman AMA
    Anticancer Agents Med Chem; 2022; 22(8):1611-1621. PubMed ID: 34515014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growth.
    Gowda R; Sharma A; Robertson GP
    Cancer Lett; 2017 Jan; 385():243-250. PubMed ID: 27769779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells.
    Lev-Ari S; Strier L; Kazanov D; Elkayam O; Lichtenberg D; Caspi D; Arber N
    Rheumatology (Oxford); 2006 Feb; 45(2):171-7. PubMed ID: 16249246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
    Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
    Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulating the Golgi apparatus by co-delivery of a COX-2 inhibitor and Brefeldin A for suppression of tumor metastasis.
    Yu RY; Xing L; Cui PF; Qiao JB; He YJ; Chang X; Zhou TJ; Jin QR; Jiang HL; Xiao Y
    Biomater Sci; 2018 Jul; 6(8):2144-2155. PubMed ID: 29923556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative effects of selective cyclooxygenase-2 inhibitor modulated by nimotuzumab in estrogen-dependent breast cancer cells.
    Wang YX; Gao JX; Wang XY; Zhang L; Liu CM
    Tumour Biol; 2012 Aug; 33(4):957-66. PubMed ID: 22252523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
    Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperine and Celecoxib synergistically inhibit colon cancer cell proliferation via modulating Wnt/β-catenin signaling pathway.
    Srivastava S; Dewangan J; Mishra S; Divakar A; Chaturvedi S; Wahajuddin M; Kumar S; Rath SK
    Phytomedicine; 2021 Apr; 84():153484. PubMed ID: 33667839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone.
    Altenburg JD; Bieberich AA; Terry C; Harvey KA; Vanhorn JF; Xu Z; Jo Davisson V; Siddiqui RA
    BMC Cancer; 2011 Apr; 11():149. PubMed ID: 21510869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic apoptotic effect of celecoxib and luteolin on breast cancer cells.
    Jeon YW; Suh YJ
    Oncol Rep; 2013 Feb; 29(2):819-25. PubMed ID: 23229294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling.
    Shirode AB; Sylvester PW
    Biomed Pharmacother; 2010 May; 64(5):327-32. PubMed ID: 19954924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial.
    Hamy AS; Tury S; Wang X; Gao J; Pierga JY; Giacchetti S; Brain E; Pistilli B; Marty M; Espié M; Benchimol G; Laas E; Laé M; Asselain B; Aouchiche B; Edelman M; Reyal F
    J Clin Oncol; 2019 Mar; 37(8):624-635. PubMed ID: 30702971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.